Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Nutrition and Healthy Aging|April 28, 2017
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activitySumit Bhattacharyya, Theresa Shumard, Hui Xie, et al.
Gastroenterology & Hepatology|November 15, 2023
MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative ColitisStephen B Hanauer, Gary R Lichtenstein, Michael A Kamm, et al.
Inflammatory Bowel Diseases|January 9, 2007
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximabBruce E Sands, Richard Kozarek, Jack Spainhour, et al.
The American Journal of Gastroenterology|September 13, 2008
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's diseaseKelvin T Thia, William J Sandborn, James D Lewis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2018
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated NeoplasiaNoa Krugliak Cleveland, Jacob E Ollech, Ruben J Colman, et al.
Inflammatory Bowel Diseases|October 29, 2005
Design issues and outcomes in IBD clinical trialsBruce E Sands, Maria T Abreu, George D Ferry, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|March 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trialsMarla C Dubinsky, Stefan Schreiber, Andres J Yarur, et al.
Inflammatory Bowel Diseases|June 15, 2007
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot studyKim L Isaacs, Robert S Sandler, Maria Abreu, et al.
Scientific Reports|November 21, 2015
Osteoarthritis-like pathologic changes in the knee joint induced by environmental disruption of circadian rhythms is potentiated by a high-fat dietRanjan Kc, Xin Li, Christopher B Forsyth, et al.
Pageof 23